No significant difference in GnT-V expression was observed with respect to other factors, including, smoking, T-category, clinical stage, cellular differentiation, pN positive or negative, local recurrence, lymph node metastasis, and treatment type. The gene discussed is MGAT5; the disease is metastatic malignant neoplasm in the lymph nodes.